Did you know you can place an order for Ozempic sourced from a reliable source in Singapore? While Canadian inventory is limited we offer our customers alternate solutions. Speak to a live agent today.

Save 10% off on your first order with coupon code: FIRST10OFF

CPPI.png

Lumakras

982 Reviews

Lumakras 120mg is a medication in capsule form used to treat non-small cell lung cancer with a specific genetic mutation (KRAS G12C).
Lumakras
Sotorasib

ATTENTION REQUIRED: All customer support calls and chats will be with English Reps. Should you require additional assistance in Spanish please send us an email to info@365scriptcare.com a member of our chat team and email support will send you emails in Spanish.

SHIPPING ADVISORY: Please be advised that due to Covid-19, Canada Post and USPS have both removed their shipping guarantee. Therefore, orders may take 7-10 business days to receive. Please be sure to place your order sooner rather than later. Should you not receive your medication within the quoted time please do not hesitate to give us a call at our toll free number 1-888-821-0245 to speak to a member of our customer support team. Thank you.

Product Description

Benefits of Lumakras

Lumakras offers significant benefits as a targeted therapy for non-small cell lung cancer with the KRAS G12C mutation. By inhibiting the mutated KRAS protein, Lumakras impedes cancer cell growth, providing a specific and effective treatment. Its precision in addressing this genetic alteration showcases improved outcomes for patients with this particular type of lung cancer, offering a tailored therapeutic approach

How Lumakras Works

Lumakras operates by targeting a specific genetic mutation, KRAS G12C, commonly found in non-small cell lung cancer. The active ingredient, sotorasib, inhibits the mutated KRAS protein, disrupting signaling pathways crucial for cancer cell growth. By blocking this abnormal protein, Lumakras impedes the uncontrolled proliferation of cancer cells, arresting the progression of the disease.

More About Lumakras

Lumakras is prescribed for the treatment of non-small cell lung cancer (NSCLC) in patients with a specific genetic mutation known as KRAS G12C. As a targeted therapy, Lumakras addresses this mutation by inhibiting the abnormal KRAS protein, preventing uncontrolled cancer cell growth. It is employed when the disease has progressed or when traditional treatments are not suitable.
Lumakras, like any medication, may cause side effects. Common side effects include diarrhea, nausea, fatigue, and muscle pain. Some individuals may experience respiratory issues or liver enzyme level changes. Serious side effects can include lung problems, severe skin reactions, and eye problems.
The recommended dosage of Lumakras (sotorasib) for non-small cell lung cancer with the KRAS G12C mutation is typically 960 mg once daily, orally. The medication is taken continuously until disease progression or unacceptable toxicity occurs.
In case of a potential overdose of Lumakras (sotorasib), immediate medical attention is essential. Overdosing on this medication may lead to an increased risk of adverse effects. If symptoms such as severe diarrhea, nausea, fatigue, or other unusual reactions are observed, individuals should seek emergency medical assistance or contact a poison control center.
Patients should take their missing Lumakras (sotorasib) dose as soon as they remember, on the same day. They should, however, forgo the missed dose and continue the regular dosing schedule if it is less than 12 hours before the next planned dose.
Lumakras use requires caution. Regular monitoring for respiratory issues, liver enzyme changes, and skin reactions is crucial. Serious side effects may include lung problems, severe skin reactions, and eye problems. Pregnant individuals should avoid Lumakras. Patients should promptly report any unusual symptoms to healthcare providers.
Proper storage of Lumakras (sotorasib) is essential for maintaining its efficacy. Store the medication at room temperature, away from excessive heat, moisture, and direct sunlight. Keep Lumakras in its original packaging and ensure it is out of reach of children. Lumakras (sotorasib) represents a targeted and innovative therapy for non-small cell lung cancer with the KRAS G12C mutation. By inhibiting the abnormal KRAS protein, it offers a tailored approach, showcasing significant benefits for patients with this specific genetic alteration.
You can conveniently buying Lumakras online through 365 Script Care, a reputable online pharmacy partner based in Canada. Experience the convenience and reliability of obtaining your Actonel through this trusted source.

📢 MOUNJARO IS NOW AVAILABLE. It's an alternative to Ozempic. Save up to 70%. Use code 365SCMOUNJARO10OFF for an additional 10% off. Chat now to order!